Galmed pharmaceuticals q2 loss per share $0.26

Galmed pharmaceuticals provides business update and reports second quarter 2020 financial results.q2 loss per share $0.26.q2 earnings per share estimate $-0.31 -- refinitiv ibes data.
GLMD Ratings Summary
GLMD Quant Ranking